WallStreetZenWallStreetZen

NASDAQ: ACLS
Axcelis Technologies Inc Stock

$136.57+8.29 (+6.46%)
Updated Jun 12, 2024
ACLS Price
$136.57
Fair Value Price
$189.84
Market Cap
$4.44B
52 Week Low
$93.77
52 Week High
$201.00
P/E
17.88x
P/B
4.93x
P/S
3.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.13B
Earnings
$250.16M
Gross Margin
44.6%
Operating Margin
25.69%
Profit Margin
22.2%
Debt to Equity
0.45
Operating Cash Flow
$165M
Beta
1.72
Next Earnings
Jul 31, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ACLS Overview

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.

Zen Score

Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACLS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACLS ($136.57) is undervalued by 28.06% relative to our estimate of its Fair Value price of $189.84 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ACLS ($136.57) is significantly undervalued by 28.06% relative to our estimate of its Fair Value price of $189.84 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ACLS is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ACLS due diligence checks available for Premium users.

Be the first to know about important ACLS news, forecast changes, insider trades & much more!

ACLS News

Valuation

ACLS fair value

Fair Value of ACLS stock based on Discounted Cash Flow (DCF)
Price
$136.57
Fair Value
$189.84
Undervalued by
28.06%
ACLS ($136.57) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ACLS ($136.57) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ACLS is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACLS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
17.88x
Industry
42.89x
Market
30.03x
ACLS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ACLS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

ACLS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.93x
Industry
13.34x
ACLS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACLS's financial health

Profit margin

Revenue
$252.4M
Net Income
$51.6M
Profit Margin
20.4%
ACLS's Earnings (EBIT) of $290.04M... subscribe to Premium to read more.
Interest Coverage Financials
ACLS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.3B
Liabilities
$404.9M
Debt to equity
0.45
ACLS's short-term assets ($1.11B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACLS's short-term assets ($1.11B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACLS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ACLS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$42.2M
Investing
-$55.7M
Financing
-$18.1M
ACLS's operating cash flow ($164.53M)... subscribe to Premium to read more.
Debt Coverage Financials

ACLS vs Semiconductor Equipment Stocks

TickerMarket Cap1d %P/EP/B
ACLS$4.44B+6.46%17.88x4.93x
IPGP$3.99B+2.80%22.53x1.71x
CAMT$5.21B+2.99%60.47x11.75x
VECO$2.59B+3.95%-127.11x3.77x
KLIC$2.57B+1.67%-38.89x2.54x

Axcelis Technologies Stock FAQ

What is Axcelis Technologies's quote symbol?

(NASDAQ: ACLS) Axcelis Technologies trades on the NASDAQ under the ticker symbol ACLS. Axcelis Technologies stock quotes can also be displayed as NASDAQ: ACLS.

If you're new to stock investing, here's how to buy Axcelis Technologies stock.

What is the 52 week high and low for Axcelis Technologies (NASDAQ: ACLS)?

(NASDAQ: ACLS) Axcelis Technologies's 52-week high was $201.00, and its 52-week low was $93.77. It is currently -32.05% from its 52-week high and 45.64% from its 52-week low.

How much is Axcelis Technologies stock worth today?

(NASDAQ: ACLS) Axcelis Technologies currently has 32,532,498 outstanding shares. With Axcelis Technologies stock trading at $136.57 per share, the total value of Axcelis Technologies stock (market capitalization) is $4.44B.

Axcelis Technologies stock was originally listed at a price of $95.76 in Jul 11, 2000. If you had invested in Axcelis Technologies stock at $95.76, your return over the last 23 years would have been 42.62%, for an annualized return of 1.56% (not including any dividends or dividend reinvestments).

How much is Axcelis Technologies's stock price per share?

(NASDAQ: ACLS) Axcelis Technologies stock price per share is $136.57 today (as of Jun 12, 2024).

What is Axcelis Technologies's Market Cap?

(NASDAQ: ACLS) Axcelis Technologies's market cap is $4.44B, as of Jun 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Axcelis Technologies's market cap is calculated by multiplying ACLS's current stock price of $136.57 by ACLS's total outstanding shares of 32,532,498.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.